WEST PHARMACEUTICAL SERVICES INC WST
출처: SEC EDGAR XBRL companyconcept (10-K) · 통화 USD
검증 ✓ 매출·재무 = SEC EDGAR XBRL companyconcept (10-K) 공시원본 (AI 추정 0) ✓ 재무 신호 = 공시 숫자 계산 (AI 아님)
$830M$1.7B$2.5B$3.3B $3.1B 20082025
🏭 사업부 흥망 해부도(성장·고전·철수·실패) 펼쳐보기 →
재무 신호 · 공시 숫자 계산 · AI 아님 · 판정 없음
✦ 흥망사
버튼을 누르면 위 공시 숫자에 근거한 흥망사를 생성합니다 — AI 서술, 예측·투자조언 없음.
▾ 데이터 표 보기
연도 매출영업이익순이익자산부채 FCF 영업이익률 매출 YoY
2008 $1.1B$124M$86M -$4M 11.8%
2009 $1.1B$98M$73M$1.3B$692M $33M 9.2% ▲ 0.4%
2010 $1.1B$91M$65M$1.3B$669M $67M 8.2% ▲ 4.6%
2011 $1.2B$110M$1.4B$744M $35M 9.2% ▲ 7.9%
2012 $1.3B$135M$1.6B$835M $56M 10.7% ▲ 6.2%
2013 $1.4B$162M$1.7B$765M $69M 11.9% ▲ 8.1%
2014 $1.4B$182M$1.7B$713M $71M 12.8% ▲ 3.9%
2015 $1.4B$129M$1.7B$671M $81M 9.2% ▼ 1.5%
2016 $1.5B$195M$1.7B$599M $49M 12.9% ▲ 7.8%
2017 $1.6B$226M$1.9B$583M $133M 14.1% ▲ 6.0%
2018 $1.7B$240M$207M$2B$583M $184M 14.0% ▲ 7.4%
2019 $1.8B$297M$242M$2.3B$768M $241M 16.1% ▲ 7.1%
2020 $2.1B$407M$346M$2.8B$939M $298M 19.0% ▲ 16.7%
2021 $2.8B$752M$662M$3.3B$978M $331M 26.6% ▲ 31.9%
2022 $2.9B$734M$586M$3.6B$932M $439M 25.4% ▲ 2.0%
2023 $2.9B$676M$593M$3.8B$949M $415M 22.9% ▲ 2.2%
2024 $2.9B$570M$493M$3.6B$961M $276M 19.7% ▼ 1.9%
2025 $3.1B$585M$494M$4.3B$1.1B $469M 19.0% ▲ 6.3%